Medicskin Holdings Limited provided group earnings guidance for the six months ended 30 September 2018. The board of directors of the company informed the shareholders of the company (the "Shareholders") and potential investors that, based on the preliminary assessment of the Group's unaudited consolidated management accounts for the six months ended 30 September 2018 and other information currently available, the Group expects to record an unaudited consolidated loss attributable to owners of the Company of approximately HKD 3.0 million for the six months ended 30 September 2018 (the "Consolidated Loss"), as compared to a net profit of approximately HKD 1.0 million for the corresponding period in 2017. The Board considers that such Consolidated Loss was mainly attributable to the combined effect of: the initial start-up expenses and additional costs (including endorsement fee) of approximately HKD 4.2 million incurred by the Group during the current period on the development of its new anti-aging centre located in Tsim Sha Tsui which commenced formal operation in June 2018; and a decline of approximately HKD 5.0 million, or 16.7%, of the revenue of the Group for the six months ended 30 September 2018 as compared to same period last year due to ongoing keen competition in the market.